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INTRODUCTION 
 
Arthur von Hippel performed the first LKP in the last quarter of the 19th 
century. The basic principle is to replace only that part of the cornea that is 
diseased and leave the recipient’s normal corneal layers intact.1,2 The idea is to to 
do the least amount of resection with the greatest amount of benefit thus leaving 
the healthy endothelium and Descemet’s membrane as an immunological barrier to 
rejection.  Deep anterior lamellar keratoplasty (DALK) is a surgical procedure for 
removing the corneal stroma down to Descemet’s membrane.3 It is most useful for 
the treatment of corneal disease in the setting of a normally functioning 
endothelium.  
Traditionally, penetrating keratoplasty (PK), which involves a full-thickness 
corneal graft, has been the treatment of choice for corneal stromal diseases. But PK 
can be complicated by graft rejection, irregular astigmatism and corneal 
opacification, thus resulting in visual impairment. DALK offers an alternative 
procedure that may lessen those risks because the recipient Descemet’s membrane 
and endothelium are preserved. At the same time, DALK carries the potential 
danger of decreased visual acuity due to possible opacification at the interface 
layers3,4. But, inspite of DALK being a procedure which does not involve 
manipulation of the anterior chamber, there is a continued endothelial cell loss. 
 
ANATOMY 
The cornea is a transparent, avascular watch glass like structure forming the 
anterior one sixth of the eyeball. It forms the principal refractive surface, contains 
the intraocular pressure and provides a protective interface with the environment. 
These functions can be subserved by virtue of a specialized substructural 
organization.5 
Histologically, the cornea is composed of five layers: 
¾ Epithelium 
¾ Bowman’s membrane 
¾ Stroma or substantia propria 
¾ Descemet’s membrane 
¾ Endothelium 
 
 
 
 
 Photomicrograph of normal human cornea showing the stratified squamous 
epithelium (EP), Bowman’s membrane (BWM), stroma (STR), Descemet’s 
membrane (DM) and endothelium (EN)  
 
1. Corneal epithelium: 
It is stratified, squamous and non-keratinized. It is 50 to 90 micron thick and 
consists of 5 or 6 layers of nucleated cells. The epithelial cells are arranged in three 
zones: 
• Deep zone: It consists of a single layer of basal columnar cells and forms the 
germinative zone. 
• Middle zone: It comprises of 2 to 3 layers of polyhedral cells called wing 
cells which are convex anteriorly and cap the basal cells. 
• Superficial zone: It has 2 to 3 layers of flattened nucleated cells called 
squamous cells. 
2. Bowman’s layer: 
It is a narrow, acellular, homogeneous zone, 8 to 14 micron thick, immediately 
subjacent to the basal lamina of the epithelium. 
It is relatively resistant to trauma due to the compact arrangement of collagen but 
once destroyed, it can’t be regenerated. 
 
 
 
 
 3. Stroma or substantia propria: 
It is around 560 micron thick (90% of the thickness of cornea) and 
comprises of regularly arranged lamellae of collagen bundles in a proteoglycan 
ground substance with cells called keratocytes. 
The lamellar arrangement is less precise in the anterior stroma. 
4. Descemet’s membrane: 
It is a 10 to 12 micron thick basal lamina produced by the endothelium. Its 
peripheral termination is marked by the Schwalbe’s line. The major protein is type 
IV collagen.  Descemet’s membrane readily regenerates following injury. 
5. Endothelium: 
The endothelium is the single layer of cells located at the posterior of the 
cornea; it permits the passage of nutrients from the aqueous humor into the cornea. 
The requirement for a monolayer that is “leaky” to aqueous humor is met through 
the barrier function of the endothelium, formed by cell-to-cell contacts and 
interdigitating lateral membranes. The endothelium is the major cell layer 
responsible for maintaining the relatively low level of stromal hydration necessary 
for corneal transparency. Stromal hydration is controlled by the activity of ionic 
pumps in the plasma membrane of endothelial cells. The relatively high 
extracellular ion concentration produced by these pumps draws water from the 
stroma, thus maintaining the highly organized collagen lamellar structure required 
for corneal transparency. The endothelium also secretes a thick basal lamina, 
termed Descemet's membrane, which lies between the endothelial cells and the 
posterior stroma. Descemet's membrane is one of the thickest basement membranes 
found in normal tissue; however, its specific function is unknown.5,6 
Morphologic Characteristics 
 
At birth, the endothelial monolayer consists of about 400,000 cuboidal cells. 
Each cell is 4 to 6 µm thick, is about 20 µm wide, and has a surface area of about 
250 µm2. The average cell density at birth is about 4000 cells/mm2.In young 
corneas, the endothelium forms a pattern of polygonal cells with five to seven 
sides. Scanning electron microscopy of the monolayer surface  reveals the 
hexagonal cell shape and numerous lateral, interdigitating cellular processes. These 
processes increase the area of contact between neighboring cells and resemble 
interlocking fingers. Occasionally, a centrally located cilium, about 2 to 7 µm long, 
is present on the surfaces of peripheral cells. The function of this cilium is unclear. 
 
Ultrastructural Characteristics 
 
The ultrastructural features of the endothelium reflect its functions. 
Numerous mitochondria within the cytoplasm indicate that these cells are 
metabolically active. The cytoplasm also contains an elaborate rough and smooth 
endoplasmic reticulum, numerous ribosomes, and a prominent Golgi apparatus 
reflective of a high level of protein synthesis. A circumferential band of actin-
containing microfilaments is located beneath the apical plasma membrane at the 
cell periphery and most likely is involved in maintaining cell shape and mediating 
cellular movement. Endothelial cells synthesize and secrete a thick basal lamina 
known as Descemet's membrane. Focal areas of increased electron density are 
present on the cytoplasmic aspect of the basal plasma membrane and may 
represent a form of adhesion plaque anchoring the endothelium to Descemet's 
membrane. Cytoplasmic processes extend from the basal aspect of the cells and 
penetrate Descemet's membrane, possibly contributing to increased adhesiveness 
of the monolayer.Focal tight junctions (maculae occludentes) on the apical aspect 
of the lateral membranes are small areas in which the outer leaflets of the plasma 
membranes of adjacent cells appear to fuse, obliterating the extracellular space. 
These junctional complexes do not form belts or rings extending around the cell, as 
are found in epithelia; rather, they occur as small zones of membrane fusion 
around the cell circumference. Electrical resistance across the endothelial 
monolayer is low (73 ± 6 ohm/cm2) compared with that across the corneal 
epithelium (1.6 to 9.1 kiloohm/cm2), reflecting the different organization of tight 
junctions in these two tissues. Gap junctions formed between adjacent cells are 
located at all levels of the lateral plasma membrane below the tight junctional 
complexes. They possess a characteristic pentalaminar structure and are the site of 
electrical and metabolic coupling, which facilitates cell-to-cell communication. 
 
 
 
 
 
 
 
 
 
PHYSIOLOGY 
Barrier Function: 
As an avascular tissue, the cornea receives oxygen mainly from the 
environment through the tear film, but its nutritional requirements are met by the 
aqueous humor. As such, the glucose, amino acids, and vitamins needed by the 
epithelial cells and stromal keratocytes must traverse the corneal endothelial 
monolayer. This nutrient transport occurs primarily through a paracellular route; 
that is, solutes move between the cells rather than being actively transported 
through them. This form of transport requires that the endothelial monolayer be 
leaky to substances within the aqueous humor but not permit bulk fluid flow into 
the corneal stroma. The barrier to bulk fluid flow from the aqueous humor to the 
stroma is formed primarily by the focal tight junctions of the endothelium. 
Experiments with molecular tracers indicate that small molecules do not penetrate 
the tight junctions but rather enter the intercellular spaces by leaking around 
them.Gap junctions and the sinuous, elaborate interdigitation of the lateral plasma 
membranes together may form a secondary barrier to fluid flow. Gap junctions 
narrow the width between apposing cell membranes from the normal intercellular 
gap of 25 to 40 nm to about 3 nm.Narrowed intercellular spaces produced by the 
formation of gap junctions, in addition to the requirement that fluid must move 
between the sinuous interdigitating lateral membranes, help prevent bulk fluid flow 
across the endothelial monolayer.7 
Pump Function: 
Transparency is essential for the function of the cornea as the primary lens 
of the eye. Transparency results from the uniformity of the tissue elements 
comprising the cornea and from the regularity of their spatial organization. Precise 
arrangement of the collagen bundles within the corneal stroma is especially 
important for corneal clarity.This precise arrangement depends to a great extent on 
the maintenance of a relatively low level of stromal hydration. Proteoglycans 
associated with the collagen fibrils within the stroma bind water, producing a 
natural pressure gradient across the endothelial monolayer. In addition, loss of 
integrity of the endothelial cell layer can hydrate the stroma. The disorganization 
of collagen fibrils that results from stromal swelling causes light absorbance, 
corneal clouding, and reduced vision. 
The endothelium maintains a low level of stromal hydration by the activity 
of ionic pumps. Studies suggest that metabolic energy is needed to maintain 
normal corneal thickness. This energy requirement appears to be associated with 
the activity of specific adenosine triphosphatases (ATPases), located in the lateral 
plasma membrane, that catalyze ion exchange. These ATPases, which act as the 
metabolic pump, are believed to function by creating a net ionic flux from the 
intracellular to the extracellular milieu. The osmotic gradient produced causes 
water to be drawn passively from the stroma to the aqueous humor. At least two 
active transport systems appear to contribute to the pumping mechanism: an 
Na+,K+-ATPase pump and a bicarbonate-dependent Mg2+-ATPase pump. 
The requirement that the endothelium permit passage of nutrients into the 
cornea and, at the same time, maintain a barrier to the free flow of water into the 
stroma presents an interesting cell biologic paradox. The pump-leak hypothesis 
attempts to resolve this paradox, stating that the rate of leakage of water and 
solutes into the corneal stroma is balanced by the rate of pumping of excess water 
from the stroma back to the aqueous. As long as the equilibrium suggested by this 
hypothesis is maintained, the corneal stroma remains relatively dehydrated, and 
corneal clarity is maintained. Figure 56–14 illustrates this equilibrium. Any 
imbalance between the rate of fluid leak into the cornea and the rate of ionic 
pumping of fluid out of the cornea results in corneal swelling and loss of visual 
acuity. 
 
Cell Division and Monolayer Repair 
Corneal endothelial cells are capable of normal division during fetal 
development; however, the total corneal endothelial cell reserve is limited because 
cell division in adult cells is limited.At birth, endothelial cell density is 3500 to 
4000 cells/mm2; in adults, this density is reduced to 1400 to 2500 cells/mm2.Cell 
density begins to decrease during fetal development as a result of both a rapid 
growth in corneal size and the limited mitotic activity that occurs after the second 
trimester of pregnancy. Once rapid corneal growth subsides, cell density continues 
to decrease, but at a slower rate. Beginning at about the second year of life, 
decreased cell density is directly related to endothelial cell loss and the inability of 
the endothelium to reproduce in numbers sufficient to keep pace with this loss.The 
overall rate of cell loss accelerates if the endothelium is injured from trauma, 
disease, or dystrophy.1,8  
Polymegathism (i.e., heterogeneity in cell size) increases in the endothelium 
with age and as the result of damage caused by trauma, corneal infection, or 
disease. Cell size can become heterogeneous for several reasons. When the 
endothelium is injured or when cells are lost because of normal attrition, repair of 
the defect in the monolayer occurs mainly through enlargement and spreading of 
neighboring cells, causing cells to be larger in these areas.In addition, the number 
of multinucleated cells and cells with greater than the normal diploid DNA content 
increase with age, producing a population of very large cells. Increased 
heterogeneity in cell shape (i.e., pleomorphism) also occurs with age or trauma.As 
the number of cells within the monolayer decreases and the cells enlarge, there is a 
decrease in the percentage of hexagonal cells within the monolayer. As 
polymegathism and pleomorphism increase, the endothelial monolayer can become 
destabilized. It is well known that a regular hexagonal pattern provides the greatest 
cellular packing with an optimal cell-to-membrane ratio. Irregular cell sizes and 
shapes can increase surface tension within the monolayer, producing decreased 
geometric and architectural stability. 
When cell numbers are reduced as the result of aging or trauma and the 
remaining cells become larger and more pleomorphic, the ability to maintain or 
restore normal barrier and pump function can be compromised.With decreased 
monolayer stability, permeability increases, and the cornea can swell. 
Decompensation (i.e., loss of monolayer integrity and function) can occur when 
cell density falls below 300 to 400 cells/mm2 or when the mean cell size reaches 
about 3000 to 3500 µm2. Because of the stressed state of the endothelial 
monolayer under these conditions, the leak rate of fluid into the stroma becomes 
greater than the pump rate of fluid flow out of the stroma, producing stromal 
edema and corneal clouding. Transplantation is the normal recourse for 
reestablishing corneal clarity and visual acuity after decompensation of the corneal 
endothelium. 
The endothelial cells form  a uniform paving-stone mosaic of closely 
apposed polygonal cells with five to seven sides. These cells are about 20 microns 
in diameter, with a 250 square micrometer surface area. The endothelial population 
is uniformly distributed over the cornea and is symmetric in both eyes. In the 
periphery, the cells become progressively more irregular as they merge with the 
trabecular endothelium. At birth, the cell density is 4000-5000 cells/square mm 
arranged in a continuous monolayer 4-6 microns thick. As the endothelial cells 
age, they die. The adult human endothelial cells have a limited capacity to divide 
and replace aging cells. But they enlarge\, re-organize themselves, migrate and 
maintain tight junctions.  
The variables that are measured in  endothelial cells are the cell size interms 
of density, spread of the cell size in terms of standard deviation or the coefficient 
of variation and the coefficient of skewness which measures the asymmetry of the 
cell population. Cells surrounding an endothelial defect enlarge to fill the defect 
and restore the monolayer. Hence, mean size of the endothelial cell tends to be 
greater in areas of endothelial trauma. Between the ages of 5 and 80 years the cell 
densirty ranges between 4000 and 900 cells/mm2.  
Younger endothelial cells have a greater wound repair capacity and a greater 
functional reserve capacity to recover from an adverse event. Polymegathism 
describes heterogeneity in cell size, whereas pleomorphism denotes heterogeneity 
in cell shape. Both increase with age, trauma and disease. Irregular cell shapes 
produce an increased cell surface tension and decreased geometric stability. Thus, 
the less homogenous and hexagon-shaped the cell population becomes, the lower 
the capacity of the cells to withstand trauma.8 
 
 
 
 
ENDOTHELIAL CELL ANALYSIS 
Endothelial cell analysis provides important clinical information on corneal 
function and viability. The determination of the endothelial cell density (ECD) has 
become an accepted practice both clinically and in research to provide information 
on the cell layer needed to maintain corneal transparency .The potential clinical 
uses include the assessment of the endothelium in donor corneas, the monitoring of 
different anterior segment surgery techniques, and the longitudinal effects of 
intraocular surgery, such as cataract surgery or implantation of phakic intraocular 
lenses. When performing intraocular procedures, endothelial trauma should be 
minimized, and specular endothelial microscopy is recognized as being essential in 
evaluating the safety of new intraocular or corneal surgical procedures and 
intraocular lenses.8 
Many studies have been published on the relationship of endothelial cell 
density and morphology with age, gender, and ethnicity. Although investigators 
differ in their findings about the relationship of age and gender to endothelial 
characteristics, it is clear that significant differences in corneal endothelial 
properties do exist among races and ethnic groups. 
Noncontact endothelial imaging reduces the risk of corneal epithelial 
damage, artifacts due to corneal manipulation, and transmission of infection. The 
disadvantage of this method is less control over patient eye movement, and 
therefore less resolution and magnification.A sample size of 50 cells may be 
adequate to study a normal cornea that does not have excessive pleomorphism. 
Many studies have compared contact and non-contact specular microscopy and 
have shown that contact specular microscopy is accurate and reproducible in the 
determination of endothelial cell density. The mean endothelial cell density in this 
study was within the range described for normal corneas.The cell loss rate with age 
(0.6% per year) was more than that described in most previous studies (0.3–0.5% 
per year), even as in longitudinal studies in which some subjects are examined 
again at a later date, a higher annual loss rate was reported (0.3–1.1% per year). 
Endothelial cell loss also occurs in situations like trauma, surgery, contact 
lenswear and diabetes mellitus. In penetrating trauma including surgery where the 
anterior chamber is entered and manipulations are done within the anterior 
chamber, there is a possibility of direct injury to the endothelium. But in 
situationslike refractive surgeries and deep anterior lamellar keratoplasty, where 
the manipulaton is only on the surface of the cornea, endothelial cell loss is not 
expected.  
The corneal specular microscope is a reflected-light microscope that projects 
light onto the cornea and images the light reflected from an optical interface of the 
corneal tissue, most typically the interface between the corneal endothelium and 
the aqueous humor. Depending on the instrument used, the projected light can be 
in the form of a stationary slit, a moving slit, or a moving spot and the optical 
design can either be non-confocal or confocal. Although specular microscopes 
have been used primarily to evaluate the corneal endothelium, the corneal 
epithelium and stroma as well as the crystalline lens can also be visualized and 
evaluated. 
Normal corneal endothelium as photographed by specular microscopy. A quasi-
regular array of hexagonal cells all having nearly the same area is seen. 
The young normal corneal endothelium above as seen by specular 
microscopy, shows a quasi-regular array of hexagonal cells all having nearly the 
same size. With aging, trauma, and corneal disease, this regularity is lost. The goal 
of endothelial specular micrsocopy is to enable the status of the endothelium to be 
obtained by visual observation and morphometric analysis of the endothelial 
image. In general, the more the endothelial image varies from the normal 
appearance shown in the above figure, the more comporomized the endothelium, 
and the less able is the endothelium to provide its necessary functions that maintain 
corneal clarity. 
Although observation of the corneal endothelium by specular reflection 
dates back to the early part of this century and observation of excized, non-
moveable, rabbit orneas was accomplished it was not until a suitable instrument 
was developed by Laing in  that clinical specular microscopy became a viable 
method. This original clinical specular microscope gave clinical photomicrographs 
having sufficient resolution to demonstrate individual cell boundaries and to 
distinguish numerous intracellular structures. From this early instrument the 
technique of clinical specular microscopy, as we know it today, was launched. 
Over the past 20 years there has been a continual improvement in the available 
technology that has resulted in instruments that are easy to use and that give 
superior image quality as compared to the early instruments. 
 
Optical properties of a Specular Microscope10 
To properly interpret the endothelial photomicrographs obtained clinically, it 
is helpful to understand the optical principles of the specular microscope. Light 
striking a surface can be reflected, transmitted, or absorbed. Generally, some 
combination of the three effects occur, with the relative proportions depending on 
such conditions as the wavelength of the light, the relative transparency of the 
medium below its surface, and the relative refractive indices on each side of the 
surface. Of primary importance in clinical specular microscopy is the light that is 
reflected specularly (i.e. “mirror-like”) where the angle of reflection is equal to the 
angle of incidence. 
For the normal transparent cornea, most visible light incident on the 
epithelial surface is transmitted. As the light passes through the corneal tissue, 
some of it can be absorbed by the tissue and some can be reflected by nerve fibers, 
keratocytes, and other refractile objects (i.e. objects having a different index of 
refraction than the bulk corneal tissue). In the stroma of the normal cornea, most of 
the incident light is transmitted through the tissue, although a small amount is 
absorbed and/or scattered (reflected through arbitrary angles) by cellular 
organelles. With an increase in corneal edema the fraction of scattered light 
increases and can become the dominant element thus giving rise to a “hazy” 
cornea. As light strikes the posterior corneal surface, almost all of it is transmitted 
into the aqueous humor. Because there is a change in index of refraction at the 
endothelium-aqueous humor interface, about 0.022 per cent of the total incident 
light is reflected; this reflected light is captured by the clinical specular microscope 
and forms the endothelial image. 
As the illumination beam of the specular microscope passes through the 
cornea, it encounters a series of interfaces between optically distinct regions. At 
each of these interfaces, some light is reflected back toward the photomicroscope 
and some is transmitted deeper into the cornea. The greater the difference in index 
of refraction between the two regions, the greater the amount (intensity) of the 
reflected light.The more edematous the tissue, the greater the intensity of scattered 
light. A portion of the reflected and backscattered light is collected by the objective 
lens of the specular microscope and forms, at the image plane of the microscope, 
an image of that part of the cornea on which the instrument is focussed. 
A narrow slit of light from a specular microscope is focused onto the 
posterior corneal surface. The incident light illuminates, in turn, the precorneal tear 
film or a coupling medium (e.g., artificial tears, methyl cellulose, etc.) between the 
objective lens and the cornea, the epithelium, Bowman's membrane, the stroma, 
Descemet's membrane, the endothelium and the aqueous humor. Within each of 
these regions, in the absence of corneal edema, only a small amount of light is 
scattered back towards the image plane, while at the major optical interfaces 
(labeled 1,2,and 3) much more light is specularly reflected back toward the image 
plane. Using indices of refraction for the objective lens, saline, cornea, and 
aqueous humor of 1.517, 1,333, 1,376, and 1.336, respectively, the fraction of light 
reflected from each of these interfaces can be calculated to be 0,36% from the 
objective lens-saline interface, 0.025% from the saline-corneal epithelium 
interface, and 0.022% from the corneal endothelium-aqueous humor interface. 
Intracorneal optical interfaces (e.g., between epithelium and Bowman's membrane 
or between stroma and Descemet's membrane, etc) also reflect light, but the 
fraction of reflected light cannot be calculated because the index of refraction of 
the separate layers of the cornea has never been measured.11,12 
At the image plane of the specular microscope, light from various corneal 
regions and interfaces overlaps. Whenever a bright region and a dark region 
overlap, the dark region is not seen. If a sufficiently narrow slit of incident light is 
used, one can generally distinguish a bright region (Zone 1), part of the stromal 
region (Zone 2), the endothelial region (Zone 3), and part of the aqueous humor 
(Zone 4). Zone 1 is formed by light reflected from the lens-coupling fluid or the 
coupling fluid-epithelial interfaces or both, depending on the index of refraction of 
the coupling fluid used.13, 14, 15 
The demarcation line between Zone 3 and Zone 4 that separates the 
illuminated cornea from the nonilluminated structures located more posteriorly, is 
called the dark boundary. One side of the boundary is dark because negligible light 
is scattered from the aqueous humor. In contrast, the demarkation line between 
Zone 2 and Zone 3 is called the bright boundary. This boundary separates the 
endothelial reflection from the overlying illuminated corneal stroma. Since some 
light is scattered from the stroma, neither side of the boundary is dark. 
. In scanning slit and scanning spot confocal specular microscopes, the slit 
width (or spot diameter) is made very small to give, at least in theory, an increased 
image quality and the large field desired is accomplished by moving the 
illuminated slit (or spot) over the endothelium, stromal nerves, keratocytes, etc.13, 
16, 17 
Using a narrow slit four distinct zones are seen; with a wide slit only three 
zones are apparent. A bright zone, Zone 1, arises from the reflection at the 
objective lens-epithelial cell interface. Zone 2 arises from light diffusely scattered 
from corneal stroma and is present only in narrow slit photographs. This zone is 
darker in clear corneas and brighter in edematous corneas. Zone 3 shows the 
endothelial cell pattern produced by light specularly reflected from the posterior 
corneal surface, while Zone 4, the dark zone, is the product of light scattered from 
the aqueous humor. Since little light is scattered in the aqueous humor and 
virtually no light from the region normally returns to the collection optics of the 
microscope, Zone 4 is generally dark. In eyes with considerable debris in the 
anterior chamber this zone occasionally can be brighter and show some structure, 
but in most instances it is uniformly dark.18, 19 
Qualitative Morphometric Analysis of Specular Images 
Both qualitative and quantitative assessments of the corneal endothelium can 
be made. Qualitative cellular analysis identifies abnormal endothelial structures 
and grades the endothelium either according to the number or size of the abnormal 
structures present or on the basis of an overall visual assessment of endothelial 
appearance. The goal is to provide a subjective evaluation of the endothelium, not 
to assign a precise numerical value to the specular photomicrograph. This type of 
analysis provides a rapid clinical evaluation of the endothelium to assess the risks 
of intraocular surgery, to establish a diagnosis, or to decide upon treatment. 
Complete qualitative analysis requires that several parameters be evaluated 
including cell conformation, cell boundaries and their intersections, configuration 
of the dark boundary, and the presence of acellular structures. One must be careful 
to eliminate optical artifacts from consideration when performing either qualitative 
or quantitative analysis of the corneal endothelium. 
Cell Conformation20, 21, 22 
The specular microscope shows A pattern of contiguous cells having well 
defined cell boundaries. The central endothelial cells of young people with normal 
eyes are hexagonal and approximately the same size; the distribution of cell area is 
approximately Normal (Gaussian). With age, the average cell area increases, the 
cellular pattern becomes distinctly pleomorphic, and the cell size distribution 
becomes skewed toward larger cell areas. In young people with normal eyes the 
cell side lengths are all roughly equal. In older individuals, the side lengths lose 
this regularity and one sees an increasing variation. 
Variations in the configuration of the corneal endothelium. A, Elongated cells. B, 
Cell 
having scalloped edges. C and D, Round cells. E, Square cell. F, Triangular cell. 
In addition to changes in size, endothelial cells may assume a shape that is 
substantially different from the usual quasi-hexagonal configuration. Figure A 
shows endothelial cells that are both enlarged and elongated. These cells were 
encountered near the corneal apex in a case of keratoconus. They appear to be 
aligned in the same direction and to follow lines of stress as if they have been 
stretched by gross deformation of the cornea. Cells with scalloped rather than 
conventional straight sides are occasionally seen (Fig. B). So, too, are round cells 
(Fig. C and D), square cells (Fig. E), and triangular cells (Fig. F). As in the case 
with changes in endothelial cell size, alterations in shape have not been directly 
related to changes in the physiologic function of the affected cells. 
 
Miscellaneous Structures 
 
 
 
.  
A number of inter- and intra-endothelial cell structures, which may be either 
dark or bright in appearance, are seen in endothelial photographs. One type of dark 
structure disrupts the endothelial cell pattern and can range in size from a structure 
smaller than a single cell to one larger than an individual endothelial cell. Each 
such structure generally has dark sides and a central bright spot (Fig. A). Such 
structures represent a smooth excrescence of Descemet's membrane (i.e., cornea 
guttatae) and often are surrounded by a ring of abnormally shaped cells. Cornea 
guttate can be seen at a much earlier stage with the specular microscope than with 
the conventional slit-lamp biomicroscope.  When these excrescences are abundant, 
they begin to touch one another and to coalesce. One sees this pattern illustrated in 
Fig. B; although the endothelial cell pattern is not visible, the bright reflection from 
the apex of each excrescence is clearly seen.  
Two additional types of dark bodies, both intracellular in location, have been 
observed. The first type is small, generally located in the central or paracentral 
portion of the cell, and has sharp, well-defined edges showing that it is located on 
the posterior surface of the cell (Fig. F). This structure has been seen in clinically 
normal corneas, and when present, it occurs in many but not all cells. It 
presumably represents the base of an endothelial cilia, although histological 
verification of this has not yet been obtained. The second type of dark body is 
considerably larger and has indistinct edges, suggesting that it is located within the 
cell (Fig. G). It may represent an intracellular vacuole or bleb. 
Intercellular dark structures, lying predominantly at endothelial cell 
intersections, have been observed (Fig. H).They tend to be uniform in size, and 
within a given frame they are randomly positioned across the endothelial cell 
pattern. These structures occur in patients with anterior uveitis, and it is believed 
they represent invading inflammatory cells. 
Intracellular bright structures, some of which may be only the cell nucleus, 
have been seen in endothelial photomicrographs.They are variable in size and 
typically are contained completely within a single endothelial cell (Fig. C and D).  
Occasional exceptions do occur, however, where the bright structure seems 
to cross a cell boundary. These intracellular bright structures appear to be 
associated with stressed cells, explaining why they commonly are seen within 
enlarged cells such as those encountered in successful corneal transplants. Their 
size or number (multiple bright structures may occur within a single greatly 
enlarged cell) seems to be proportional to the size of the cell. That is, the larger the 
endothelial cell, the larger the intracellular bright structure. 
 
A second type of bright structure spans several endothelial cells (Fig. E) and 
is positioned at random on the endothelial cell pattern of the specular 
photomicrographs. When viewed directly, these structures appear to sparkle; some 
are orange, while others are white. Slit-lamp biomicroscopy of these corneas 
reveals numerous pigment deposits on the endothelium. The bright structures seen 
with the clinical specular photomicroscope appear to correspond to the pigmented 
endothelial deposits seen with the slit-lamp biomicroscope, and presumably they 
are the same abnormality. 
Morphologic variations in endothelial cell configuration, cell surface 
properties, and intercellular boundaries, as well as the presence of numerous 
intracellular structures, can be identified by the clinical specular microscope. 
Although the nature and significance of many of these abnormalities are not 
presently known, their recognition represents an initial step in the elucidation of 
their pathophysiological significance. 
Quantitative Morphometric Analysis of Specular Images 
Although a qualitative description of the corneal specular image suffices for 
many applications, more quantitative information is desirable for others. The aim 
of quantitative analysis is to assign a number (or set of numbers) to the specular 
photomicrograph that can provide a measure of the endothelial status. 
Various of morphological parameters that can be quantified. These include cell 
size (cell area or cell density), polymegathism (variation of cell size such as 
coefficient of variation of mean cell area), pleomorphism (variation of cell shape 
such as percent of hexagonal cells or coefficient of variation of cell shape), cell 
perimeter, average cell side length, cell shape, and so forth. Histograms or 
frequency distributions of these quantities can also be determined. To date only 
cell size, pleomorphism, and polymegathism and several variables related to these 
parameters have proven useful in determining endothelial status.23, 24 
Two equivalent parameters have been used to quantify endothelial cell size. 
They are mean cell area and cell density (or cell count). Cell area has most often 
been expressed in units of µm² per cell and cell density in units of cells per mm². 
The two quantities are related by the following equations: 
Mean cell area (µm²/cell) = 10E6/cell density (cells/mm²) 
or 
Cell density (cells/mm² = 10E6/mean cell area (µm²/cell) 
Two different methods, fixed frame analysis and variable frame analysis, 
can be used to measure either of these two parameters of cell size. 
Fixed Frame Analysis of Cell Size 
In fixed frame analysis one counts the number of cells within a frame or 
window of constant area. All cells lying completely within the frame are counted 
as whole cells. However, along the boundary of the frame there are many cells that 
lie only partly in the frame, and for these cells it is usually impossible to determine 
the fraction of the cellular area that lies within the borders of the frame. Each cell 
that is only partially within the frame is counted as one half cell regardless of the 
fractional area of that cell located within the frame. The total number of cells (the 
cell count) is then taken as the sum of the number of whole and half cells within 
the frame. To speed up the counting process one commonly invokes a symmetry 
principle and counts all cells cut by two sides of the frame as whole cells and does 
not count those cells cut by the other two sides of the frame. As long as the number 
of boundary cells is small compared to the total number of whole cells within the 
frame, and cellular pleomorphism is not too great, this method can give reasonably 
accurate values for mean cell size. The size is obtained by dividing the cell count 
by the area of the frame and expressed as cell density in cells per mm². The area of 
the frame must be referred to the endothelium. This is accomplished by dividing 
the actual area of the frame by the square of the linear magnification of the 
specular microscope, and if the cells were counted from an enlargement of the 
negative, by the square of the linear magnification of the enlargement. One can 
also divide the area by the cell count and report mean cell area as well. In practice, 
except for very rough estimates of cell count, a minimum of 35 contiguous cells 
should lie within the counting frame, although for most studies it is preferable to 
have 50 to 100 cells within the counting frame. Otherwise the errors associated 
with the counting method itself will generally be too large to provide meaningful 
numbers.25 
Variable Frame Analysis of Cell Size 
Variable frame analysis, originally proposed by Laing, is most conveniently 
done using a computer based analysis system such as the Bambi system (Bio-
Optics, Inc. Arlington, MA). This method eliminates the problem of counting 
fractional cells along the boundary, thus providing a more accurate determination 
of mean cell size than fixed frame analysis, again assuming that cellular 
pleomorphism is not too great and that the cell sample is representative of the area 
under study.In variable frame analysis, one first measures the variable area 
occupied by an integral number of cells by tracing around a contiguous group of 
cells with a mouse. The user then marks each cell by clicking it with the mouse. 
The computer then calculates the cell density by dividing the number of marked 
cells by the area of the frame. An equivalent value, the mean cell area, can also be 
obtained by dividing the frame area by the number of cells that have been 
circumscribed. 
Using variable frame analysis, errors due to the counting method are very 
small as compared to fixed frame analysis so that many fewer cells must lie within 
the frame. Furthermore, with variable frame analysis, additional information can be 
obtained. If one traces around the smallest cell in the image and marks it, the 
computer calculates the cell density assuming that all cells are this small. If one 
then traces around the largest cell in the image and marks it, the computer 
calculates the cell density assuming that all cells are this large. These two numbers 
give the range of cell densities (or the range of cell areas) that exist in this image 
providing more information regarding the endothelium than if only the mean cell 
density is obtained.26, 27 
Individual Cell Analysis 
In fixed frame analysis only average cell size can be determined. The same 
holds true for variable frame analysis if only a group of cells is circumscribed. 
However, using the variable frame technique, single cells can be traced with the 
stylus of the planimeter or digitizer, and this then permits individual cell analysis. 
Such an analysis provides much more information about the endothelial cell 
pattern than can be obtained with methods that determine only cell density or 
average cell area. 
Individual cell analysis can be performed either manually, semi-
automatically, or fully automatically. The first computerized manual analysis 
system was developed by Laing and associates. In this system (the Bio-Optics 
Mandig system) the cell boundaries are traced with a special pen or a cross-hair 
cursor of a digitizer. As this is being done, the x and y coordinates of the boundary 
points are automatically entered into a computer. The computer determines when 
the cell has been completely circumscribed and calculates the area (or other 
programmed morphologic parameters) of that cell. It then instructs the operator to 
trace another cell. The cell density or mean cell area can be obtained by averaging 
the data on a group of cells. In addition, a frequency distribution (or histogram) of 
cell size can be obtained. Although such frequency distributions provide 
considerable information about the endothelium, few studies were done before the 
use of the personal computer since the procedure was extremely tedious. 
Laing et al10 developed semi-automated methods utilizing video images that 
eliminated much of the tedium associated with endothelial analysis. These methods 
also enabled additional morphometric parameters to be easily determined. The 
system developed (the Bio-Optics Bambi system) requires the initial digitization of 
the cells using a mouse and then calculates all of the morphometric parameters 
believed to be possibly important. The system enables the addition of new 
programs to calculate additional parameters should this be desirable. Poor 
endothelial images can be contrast-enhanced to improve them. Images and data 
files can be instantly printed, stored, retrieved, and transferred to other computers, 
as desired. This system is widely used for the evaluation of the endothelium. 
Fully automated methods of individual cell analysis in which the computer 
accomplishes the task of determining cell borders and cell apices from background 
noise in the image as well as performing the morphometric and statistical 
calculations have been under development for many years. Such fully automated 
systems have been developed by Laing and associates, by Nishi and associates by 
Hartmann and associates (which system was improved by Fabian and associates, 
by Assenbauer and associates, and by Corkidi and associates and by several 
companies that, so far, have not published the methods or computer algorithms 
used. Due largely to the complex nature of the endothelial image, (especially for 
the abnormal endothelium) all of the systems so far developed make a variety of 
errors and none have been able to obtain reliable numbers without tedious and 
time-consuming manual editing ofthe image and/or graphic cell borders calculated 
and displayed by the computer. Because of the complexity of an endothelial 
photograph, fully automated methods, at least for the foreseeable future, will 
require considerable interaction and decision-making by a human operator. 29, 30 
Endothelial wound healing mechanisms: sloughing & sliding, coalescence, and 
mitosis3, 6, 23 
Prior to the development of clinical specular microscopy it was believed that 
the only healing mechanism for the adult human corneal endothelium was the 
"sloughing and sliding" mechanism whereby damaged endothelial cells sloughed 
from the endothelium and the adjacent undamaged, or less damaged, cells moved 
laterally so as to cover the defect left by the sloughed cells. Specular microscopy 
revealed two additional healing mechanisms. Endothelial cell coalescence (cell 
fusion), is a mechanism in which the common cell membrane between two cells 
degenerates to result in a larger cell containing two nuclei and, presumably, all of 
the cellular organelles of the two individual cells. Endothelial cell mitosis, once 
generally believed to be impossible for adult human endothelial cells, has also been 
demonstrated in the adult human cornea following successful treatment for graft 
rejection. Although considerable effort has been expended to induce mitosis by the 
application of exogenous substances such as growth factors, such efforts have been 
largely unsuccessful and the trigger for endothelial cell mitosis has been elusive. 
LAMELLAR KERATOPLASTY 
 
Arthur von Hippel performed the first LKP in the last quarter of the 19th 
century. The basic principle is to replace only that part of the cornea that is 
diseased and leave the recipient’s normal corneal layers intact. The idea is to to do 
the least amount of resection with the greatest amount of benefit thus leaving the 
healthy endothelium and Descemet’s membrane as an immunological barrier to 
rejection3, 4, 6 
Types 
Inlay LK: A part of the anterior stromal lamellae of the recipient is removed 
and replaced with healthy partial thickness donor cornea, consisting o stroma, 
Bowman’s layer and epithelium. It is used to treat superficial corneal scars 
Onlay LK 
A partial thickness donor cornea is placed on a de-epithelialised cornea in 
which a small peripheral keratectomy and/or peripheral lamellar dissection has ben 
done. Epikeratoplasty done for keratoconus and keratoglobus is an example of 
onlay LK 
Anterior LK  
Encompasses both inlay and onlay LK 
Deep LK 
Deep resection or ablation of host stroma upto the level of the Descemet’s 
membrane and replacement with donor stromal button. It is performed for 
keratoconus and corneal scars. 
Posterior LK: 
The anterior layers of host cornea are preserved and the posterior layers are 
replaced. 
Indications 
Optical 
Therapeutic  
Tectonic 
Optical 
Superficial corneal scars 
Irregular/ecstatic corneas 
 
Tectonic 
Peripheral corneal thinning 
Ectatic pathologies 
Therapeutic 
Recurrent pterygium 
Conjunctival CIN 
Major indications 
Corneal dystrophies 
Aniridia keratopathy 
Corneal scars  
Keratoconus 
In developing countries 
Chemical injuries  
Trachomatous keratopathies 
Dermoids 
Criteria for LK 
Reasonably healthy host ocular surface 
Optimum endothelial function 
Corneal opacity that spares the Descemet’s membrane 
Grossly distorted cornea that precludes Contact lens fitting 
Contraindications 
Herpes simplex/zoster 
Chemical or radiation injuries 
Stevens-Johnsons syndrome 
Neurotrophic keratopathy 
Lagophthalmos with exposure keratopathy 
Severe dry eye 
DEEP ANTERIOR LAMELLAR KERATOPLASTY 
Deep anterior lamellar keratoplasty (DALK) is a surgical procedure for 
removing the corneal stroma down to Descemet’s membrane. It is most useful for 
the treatment of corneal disease in the setting of a normally functioning 
endothelium. Traditionally, penetrating keratoplasty (PK), which involves a full-
thickness corneal graft, has been the treatment of choice for corneal stromal 
diseases. But PK can be complicated by graft rejection, irregular astigmatism and 
corneal opacification, thus resulting in visual impairment. DALK offers an 
alternative procedure that may lessen those risks because the recipient Descemet’s 
membrane and endothelium are preserved. At the same time, DALK carries the 
potential danger of decreased visual acuity due to possible opacification at the 
interface layers. 
As early as the 1950s, Jose Barraquer and colleagues in Colombia applied 
new techniques of lamellar keratoplasty, dissecting the corneal stroma down to 
two-thirds of its thickness in both the donor and the recipient tissue. Yet the 
procedure failed to gain favor because of poor visual outcomes related to 
irregularity of the dissected surfaces and scarring in the tissue interfaces. Although 
exposure of Descemet’s membrane in corneal dissection was performed in the 
1970s, the term “deep lamellar keratoplasty,” as it is used today, was not employed 
until 1984 by Eduardo Arenas Archila, MD, with the use of intrastromal air 
injection to facilitate host tissue removal. By the late 1990s, studies indicated that 
DALK was associated with visual outcomes similar to PK without the risk of 
immunological rejection. In spite of positive reports in the literature, the classic 
technique of layer-by-layer stromal tissue removal was tedious and required great 
surgical experience, thereby limiting its use around the world. Recent advances in 
techniques contributed by many surgeons have started to popularize the procedure. 
Indications 
DALK can be an effective treatment for any pathology of the anterior cornea 
(epithelium, Bowman’s layer and stroma) as long as the patient has an intact, 
functioning endothelium. Common indications for DALK include keratoconus and 
corneal scars. Patients with keratoconus are good candidates for DALK because 
they are typically young and have healthy endothelium. These patients stand to 
lose the most from the occurrence of post-PK immunological reactions that can 
compromise endothelial function in up to 20 percent of cases. Less common 
indications for DALK include vernal keratoconjunctivitis, corneal dystrophies and 
ocular surface diseases with limbal stem cell deficiency, including Stevens-
Johnson syndrome, ocular cicatricial pemphigoid and chemical/thermal burns. 
 
Pros and Cons 
DALK offers a variety of theoretical and practical advantages compared with PK 
for patients with a healthy corneal endothelium. 
Pros: Anatomic outcomes  
Eighteen percent of primary full-thickness grafts have been reported to fail 
within 10 years due to endothelial rejection and chronic endothelial cell loss, and 
DALK may reduce this rejection rate because the host endothelium is preserved. In 
a randomized clinical trial comparing DALK and PK published in 2002, there was 
a significant difference in endothelial density between treatment groups at 24 
months postoperatively (2,183 ± 300 vs. 1,868 ± 272 per mm2 respectively, P = 
0.044). Furthermore, while endothelial cell density stabilized around six months 
after DALK, there continued to be loss of cells in the PK group at 24 months. 
Moreover, keratometric astigmatism rates were lower at six and 12 months after 
DALK compared with the same intervals after PK. Additionally, studies indicate a 
shorter healing time (suture removal at four months after DALK vs. 12 months 
with PK), fewer postoperative complications and shorter use of topical steroid 
treatment with the deep anterior approach. Finally, from a public health 
perspective, DALK provides the opportunity to use donor tissue with questionable 
endothelium that might not be suitable for full-thickness grafts. In the future, it 
may be possible to use the same donor cornea for a DALK and a Descemet’s 
stripping endothelial keratoplasty. 
Visual outcomes  
In spite of the clinical and theoretical advantages of lamellar keratoplasty, 
visual outcomes have not always been ideal. Visual acuities associated with older 
lamellar keratoplasty techniques were inferior to those associated with PK due to 
the tissue interface scarring that developed between the donor cornea and the 
recipient stromal bed. However, since deep lamellar keratoplasty surgery removes 
almost all of the recipient stromal tissue, the risk of scarring in the interface and 
subsequent poor visual outcomes is much reduced.  
Uncertain  
Currently, the literature is ambivalent regarding visual outcomes between 
DALK and PK. In one comparative cohort study, the proportion of patients who 
achieved a BCVA of 20/20 was significantly higher following PK compared with 
DALK (70 percent vs. 22 percent, P = 0.04); however, in another randomized, 
controlled trial, there was no statistically significant difference between the two 
procedures in associated postoperative BCVA. Ultimately, the visual result of 
DALK depends on the ability to maintain clear interfaces between the tissues. The 
femtosecond laser has been successfully used in donor human eyes to cut posterior 
lamellar flaps in endothelial keratoplasty, and this technology could potentially 
reduce tissue irregularity and scarring in DALK. 
Cons  
The disadvantages of the procedure are the complexity and novelty of the 
techniques. A learning curve exists, and cases of recipient corneal perforation 
requiring transition to PK may require another donor eye with better endothelial 
quality. 
Performing DALK6, 7 
Various approaches for performing DALK have been described in the 
literature. One method is to remove the host anterior corneal tissues layer-by-layer 
until reaching the deep stroma or the bare Descemet’s membrane. Although 
different surgical techniques vary in their details, the basic surgery consists of the 
following steps: 
Recipient eye  
The anterior corneal surface is cut with a suction trephine set to a depth of 
about two-thirds of the corneal thickness. Then the stromal layers are dissected 
with a rounded blade, angled parallel to Descemet’s membrane. Fluid or air is then 
injected using either a 27- or 30-gauge cannula in between the deep stroma and 
Descemet’s membrane to separate those layers.  Because early techniques failed to 
visualize the depth of stromal dissection, there was a greater risk of perforation 
than when Descemet’s membrane can be visualized. New techniques described 
below can decrease surgical times while improving the safety and success rates of 
DALK. 
• Intrastromal air injection. One innovation in DALK has been the use of an 
air-filled tuberculin syringe, the needle of which is injected obliquely into the 
stroma prior to trephination. This intrastromal air renders the cornea opaque and 
provides a safe deep interface for the trephine. 
• Hydrodelamination. After the initial trephination to about 75 percent of the 
corneal thickness, the surgeon can inject balanced salt solution through a 
cannula into a small pocket created in the central stroma. The saline induces 
stromal fiber swelling, which facilitates fine manipulation with forceps. 
• Viscoelastic dissection. After an initial 80 to 90 percent trephination, sodium 
hyaluoronate can be injected through a blunt cannula deep into the central 
corneal lamella near Descemet’s membrane. Injection of the viscoelastic 
substance between the deep stroma and Descemet’s membrane facilitates the 
separation of the final layers. 
• Big bubble. With the “big bubble” technique, air is injected deep into a groove 
created by trephining 60 to 80 percent stromal thickness. This introduction of 
air into the stroma anterior to Descemet’s membrane creates a dome-shaped 
detachment of Descemet’s membrane, which is then identified by a ring visible 
with the microscope. 
• Anterior chamber air. In order to obtain the best visualization during the 
surgery, Gerrit R. J. Melles, MD, PhD, suggested introduction of air in the 
anterior chamber. This injected air creates a mirror like effect that facilitates the 
movement of surgical instruments between Descemet’s membrane and the deep 
stroma. Furthermore, the air-to-endothelium interface becomes a landmark to 
identify the posterior surface of the cornea, serving as a reference for dissection 
depth. 
Donor eye 
Although preserved grafts can be used, most of the literature reports use of 
fresh corneas prepared by the surgeon. Descemet’s membrane and endothelium are 
removed by gently swabbing the posterior corneal surface of the donor 
corneoscleral rims with dry cellulose sponges. Forceps also may be used for 
removing the posterior corneal layers. Then a corneal button is punched out from 
the tissue. Suturing technique (interrupted, running or combined interrupted-
running 10.0 nylon sutures) can be done according to the surgeon’s preference in 
DALK, just as in PK. After suturing, a bandage soft contact lens is placed on the 
cornea.  
Complications 
The most frequently encountered complication of DALK is perforation of 
Descemet’s membrane and entering the anterior chamber from the stroma. 
Descemet’s membrane and the posterior cornea are especially susceptible to  
perforation by sharp instruments. Tears or perforations occur in approximately 10 
to 30 percent of cases.2 The viscoelastic dissection technique may offer some 
protection against perforation. If a perforation occurs, management depends on the 
timing and the size of the injury. If the tear occurs while the stroma still covers 
Descemet’s membrane, it generally self-seals. Small perforations occurring during 
dissection may result in postoperative Descemet’s membrane detachment. Most 
Descemet’s membrane detachments can be managed by injecting air or an air/gas 
mixture (sulfur hexafluoride + air) into the anterior chamber after surgery or under 
the slit lamp postoperatively, thereby creating a tamponade to seal the Descemet’s 
membrane defect. However, it should be noted that the use of a tamponade to 
reattach Descemet’s membrane may lead to closure of the anterior chamber angle 
from pupillary block. A rare complication occurs when a fixed, dilated pupil 
ensues secondary to iris ischemia, referred to as the Urrets-Zavalia syndrome. In 
cases where the tamponade fails to manage the perforation, a conversion to 
traditional penetrating keratoplasty might be necessary.  
Postoperative Care 
 
Topical corticosteroids and antibiotics are administered postoperatively. 
Patients are monitored for inflammation, infection, graft rejection, astigmatism and 
suture-related problems. Overall, patients tend to fare well with a shorter course of 
corticosteroids after DALK than after PK. At 12 months postoperatively in one 
study, only 15 percent of DALK patients used topical prednisolone, while 75 
percent of PK patients continued to need the treatment. In addition, sutures can be 
generally removed earlier in DALK patients than in PK patients. 
With a long history, DALK is seeing a recent renewed interest. Although 
DALK has the reputation of being challenging and time-consuming, recent 
advances in techniques have cut the surgical time considerably. In patients with 
anterior corneal opacification or structural corneal defects with a healthy, 
functioning endothelium, DALK can be considered as the first-line treatment due 
to its preservation of host endothelium and Descemet’s membrane. If future studies 
show that DALK provides lower postoperative complications, fewer graft 
rejections and similar visual outcomes compared to PK, DALK should have a 
promising future in corneal surgery as a viable alternative to full-thickness PK in 
selected patients. 
DALK AND ENDOTHELIAL CELL LOSS 
 
Though DALK has been touted to be a better procedure than PKP in the 
maintenance of the endothelial cell layer of the cornea, there have been studies 
which have proved otherwise. A study done by Patel et al at the Princess of Wales 
hospital, UK, showed that the endothelial cell loss was the same in two eyes of the 
same patient with macular dystrophy, one of which underwent a DALK and the 
other, PKP. 
Further, a study done by van Dooren BT et al at the Rotterdam Eye hospital 
Netherlands has shown that there is a significant endothelial cell loss in patients 
who underwent DALK irrespective of the antecedent etiology. The endothelial cell 
loss was significantly higher than the physiological endothelial cell loss.33, 34, 35 
  
 
AIMS OF THE STUDY 
 
a) To determine the viability of the graft after Deep Anterior Lamellar 
Keratoplasty 
b) To assess the visual acuity after Deep Anterior Lamellar Keratoplasty 
c) To determine the loss of corneal endothelial cells after Deep Anterior 
Lamellar Keratoplasty 
 
 
 
 
 
 
 
 
 
 
 
 
Inclusion Criteria 
a) Lesions involving the anterior 2/3rd of the corneal stroma 
b) No evidence of active inflammation 
c) No evidence of vascularisation of  the cornea 
d) In keratoconus patients, those that could not be corrected with spectacles or 
contact lenses. 
Exclusion Criteria 
a) Lesions involving the full thickness of the cornea 
b) Iris incarceration to the corneal lesion 
c) Presence of active inflammation 
d) Presence of vascularisation 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
The study was conducted at the Cornea Services of the Regional Institute of 
Ophthalmology, Government Ophthalmic Hospital, Chennai between June 2007 
and November 2009. 
27 eyes of 27 patients who underwent Deep Anterior Lamellar Keratoplasty 
was included in the study. 
These 27 patients underwent Deep Anterior Lamellar Keratoplasty for 
various etiologies. 
Their pre-operative visual acuity, both uncorrected and best corrected, was 
assessed using a Snellen’s chart.  
A thorough ocular examination was done. The ocular adnexa was assessed 
for the presence of any active inflammation. The eyelids were assessed for the 
presence of any lid abnormalities such as entropion/ectropion, trichiasis or 
lagophthalmos. The intergrity of the Bell’s phenomenon was assessed.The ocular 
surface was examined for the presence of inflammation. Tear film abnormalities 
were ruled out. Slit lamp biomicroscopy was done to assess the depth of the 
corneal lesion, to determine the presence of active inflammation and to rule out the 
presence of vascularisation of the cornea. The other ocular structures were 
examined for their integrity. 
All patients included in the study underwent Deep Anterior Lamellar 
Keratoplasty by the same surgeon, using the technique of lamellar dissection. 
After the patients underwent Deep anterior Lamellar Keratoplasty, their eyes 
were examined to assess the status of the graft, the uncorrected and best corrected 
visual acuity and the endothelial cell count.  
The endothelial cell count was assessed using a SP 2000P specular 
microscope (Topcon).  
The patients were followed up over a period of one year and at each visit a 
detailed ocular examination, an uncorrected and best corrected visual acuity and  a 
specular microscopic examination was done. 
 
 
 
 
 
 
 
 
 
ANALYSIS AND RESULTS 
The various etiologies for which deep anterior lamellar keratoplasty were 
performed 
Table – 1 
 
Etiology Number of eyes Percentage 
Keratoconus 8 29.6 
Corneal Dystrophy 6 22.2 
Corneal Opacity 7 25.9 
Corneal Degeneration 4 14.8 
Limbal dermoid 1 3.7 
 
 
0 
 
 
 
 
 
 
 
 
Analysis of graft status, visual acuity and endothelial cell loss in each etiology 
for which DALK was performed 
1) KERATOCONUS 
Status of graft 
Table – 2 
 
CLEAR OPAQUE PERCENTAGE 
7 1 88% 
 
  
 
 
 
 
 
 
 
 
 
Improvement In Visual Acuity 
Table - 3 
Upto 2 lines 2-6 lines > 6 lines 
4 2 1 
57.1% 28.5% 14.2% 
 
  
 
 
Endothelial cell loss 
Table - 4 
10-20% 20-40% 
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Improvement in Visual Acuity 
Table - 8 
1 line 2 lines 5 lines 6 lines 
4 1 1 1 
57.1% 14.2% 14.2% 14.2% 
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Status of the
Table - 1
 graft 
0 
OPAQUE 
2 2 
50% 50% 
 
In 1 case, the graft got infected, which was treated with antiobiotics and 
resolved.  In the other, the DALK was coupled with cataract extraction 
 
 
 
 
 
 
 
 
 
Improvement In Visual Acuity 
Table - 11 
>3 LINES <3 LINES 
2 2 
50% 50% 
 
The improvement in the visual acuity was limited to 2 cases out of 4, 
because of the fact that the other two grafts became opaque. 
 
 
 
 
 
 
 
 
 
 
 
Endothelial Cell Loss 
Table - 12 
 10-20% 
2 
20-40% 
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Comparison of pre and post-operative viusual acuities 
 
 
 
 
 
 
 
Comparison of the graft clarity 
 
 
 
 
 
 
 
The endothelial cell loss over the post-operative period 
 
 
 
 
 
 
The endothelial cell loss was seen to progressively reduce over the study period. In 
the first month, 44.4 % of grafts had an endothelial cell loss of less than or equal to 
a hundred cells. But by the sixth month, 40.7% of the grafts had an endothelial cell 
loss of between 200 and 500 cells At the end of one year’s follow up, 51.8% of the 
grafts had an endothelial cell loss of between 200 and 500.  
 
 
 
                                    
 
SUMMARY 
Patients who underwent Deep Anterior Lamellar Keratoplasty between June 
2007 and June 2009 were included in the study. 
All the patients were examined pre-operatively for their Visual Acuity and  
Diagnosis for which the surgery was going to be done 
After the surgery, the patients were examined at the end of one week. One 
month, 6 months and one year for their visual acuity, status of the graft and the 
status of the endothelium by doing a specular microscopy. 
The visual acuity improvement was present in 65 % of cases that underwent 
the surgery. 88% of patients with keratoconus and 72% with corneal dystrophies 
had a clear graft at the end of the study period. The cause of graft failure was 
invariably lack of compliance on the part of the patient. 
The endothelial cell loss was seen to progressively reduce over the study 
period. In the first month, 44.4 % of grafts had an endothelial cell loss of  less than 
or equal to a hundred cells. But by the sixth month, 40.7% of the grafts had an 
endothelial cell loss of between 200 and 500 cells At the end of one years’ follow 
up, 51.8% of the grafts had an endothelial cell loss of between 200 and 500. 
DISCUSSION 
 
DALK  is an effective treatment for any pathology of the anterior cornea 
(epithelium, Bowman’s layer and stroma) as long as the patient has an intact, 
functioning endothelium. Young patients are especially good candidates for Deep 
anterior Lamellar keratoplasty because they have a healthy endothelium. Hence, 
patients with keratoconus are good candidates for DALK because they are 
typically young and have healthy endothelium. Immunological rejection is an issue 
with Penetrating Keratoplasty, which is not so with Deep Anterior Lamellar 
Keratoplasty, since the patient’s endothelium is left intact.  In cases with corneal 
dystrophies, there is a risk of recurrence of the underlying disease in the graft. 
But, as is the case with contact lens wear, there is a continued endothelial 
Cell loss after Deep Anterior Lamellar Keratoplasty. 
The viability of the graft was found to be excellent after Deep Anterior 
Lamellar Keratoplasty. This was seen especially in cases operated for Keratoconus 
and Corneal dystrophies involving the anterior 2/3rds of the cornea. In our study, 
87.5% of the cases with keratoconus, and 100% of those with corneal dystrophies, 
had a clear graft after one year of follow up. 
The improvement in the visual acuity was very good after Deep anterior 
Lamellar Keratoplasty.  The best improvement of visual acuity was found in cases 
who underwent the procedure for keratoconus, with 37.5 % of the cases having an 
improvement of 4 lines or more. This was followed by cases who underwent the 
procedure for Corneal dystrophies, with 28.5 % of the cases having an 
improvement of 4 lines or more. 
The endothelial cell loss over a period of one year was consistent in all cases 
that underwent Deep Anterior Lamellar Keratoplasty, though there was not any 
undue post-operative inflammation The maximum endothelial cell loss was found 
to be in patients who underwent DALK for corneal degenrations or healed corneal 
opacities. 
CONCLUSION 
 
Our study proves that Deep Anterior Lamellar Keratoplasty is indeed an 
excellent procedure for anterior corneal lesions.The prognosis, in terms of visual 
acuity and viability of the graft is very good. The major cause of graft failure was 
lack of compliance on the part of the patient. The other causes were recurrence in 
case of dystrophies and graft edema due to the presence of an unhealthy 
endothelium pre-operatively. 
The prognosis in terms of visual acuity was also found to be excellent, 
especially in cases of keratoconus and corneal dystrophy. 
Though the procedure does not involve any manipulation within the anterior 
chamber which could jeopardize the health of the corneal endothelium, there is a 
continued endothelial cell loss after Deep Anterior Lamellar Keratoplasty. 
Therefore, though it has an advantage over Penetrating keratoplasty, in terms of 
less chances of endothelial rejection, there is still a continued endothelial cell loss 
after Deep Anterior Lamellar Keratoplasty. 
 
  
 
 
 
INTERFACE DEPOSITS AFTER DEEP ANTERIOR LAMELLAR KERATOPLASTY 
  
 
 
RECURRENCE OF DYSTROPHY AFTER DEEP ANTERIOR LAMELLAR 
KERATOPLASTY 
 
 
  
 
 
DEEP ANTERIOR LAMELLAR KERATOPLASTY 
  
 
 
                                                                PROFORMA 
Name 
Date 
Address 
Age 
Sex 
Date of Admission 
Date of Discharge 
I.P. no. 
Complaints: Dimuntion of vision- Duration, progression, presence/absence of pain, 
redness. 
Present History 
Past History 
Family History- any similar illness in the family 
History of Diabetes mellitus, hypertension, bronchial asthma 
General Examination 
 
 
 
 Local Examination (both eyes)   RE    LE 
Visual Axis 
Uncorrected and Best corrected visual acuity 
Lids and Adnexa 
Conjunctiva 
Cornea- depth of involvement, presence/absence of inflammation 
Anterior Chamber-presence/absence of inflammation 
Iris-presence/absence of adherence to corneal pathology 
Lens 
Pupil 
Fundus 
Intraocular Pressure 
Schirmer’s test 
Tear film Breakup time 
Specular microscopy  
Random Blood sugar 
Blood Pressure 
Urine- albumin, sugar 
Syringing of Nasolacrimal duct 
 At each visit after surgery 
Visual acuity- Uncorrected visual acuity 
   Best corrected visual acuity 
Thorough slit lamp examination to assess the status of the graft 
Specular microscopy to assess status of the endothelium 
 
 
 
 
 
  
 
 
KEY TO MASTER CHART 
 
LE    -  LEFT EYE 
RE    -  RIGHT EYE 
BE    -  BOTH EYES 
VA    -  VISUAL ACUITY 
PH    -  PIN HOLE 
NIP    -  NOT IMPROVING WITH PINHOLE 
CD    -  CELL DENSITY 
DALK   -  DEEP ANTERIOR LAMELLAR  
KERATOPLASTY 
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LIST OF SURGERIES PERFORMED 
S. 
No. 
Name Age Sex IP no. Diagnosis Surgeries 
1. Kanniammal 60 F 684392 BE IMC 
LE ECCE 
with PCIOL 
2. Chinnathai 65 F 785391 RE IMC/LE MC 
LE ECCE 
with PCIOL 
3. Elangovan 76 M 790160 RE IMC/LE MC 
LE ECCE 
with PI 
4. perumal 70 M 690437 RE IMC/LE MC 
LE ECCE 
with PCIOL 
5. Jayagopal 50 M 692899 BE IMC 
RE ECCE 
with PCIOL 
6. Subramani 57 M 793525 RE IMC/LE MC 
LE ECCE 
with PCIOL 
7. Kaliammal 68 F 783728 BE Nuclear Cat. 
RE ECCE 
with PCIOL 
8. Annammal 60 F 674267 BE MC 
LE ECCE 
with PCIOL 
9. Krishnaveni 50 F 725015 BE IMC 
LE SICS  
with PCIOL 
10. Muniyammal 65 F 816095 BE IMC 
LE SICS with 
PCIOL 
11. Dhanalakshmi 46 F 785885 BE IMC 
RE SICS 
with PCIOL 
12. Ramasamy 65 M 826095 BE IMC 
RE SICS 
with PCIOL 
13. Lourdammal 50 F 656005 
RE PSEUDO/ LE 
IMC 
LE ECCE 
with PCIOL 
14. Gopal 65 M 776441 BE IMC 
LE SICS with 
PCIOL 
15. Chandra 65 F 886336 
RE MC/ LE 
PSEUDO 
RE SICS 
with PCIOL 
16. Vellaiyan 55 M 847637 BE MC 
LE ECCE 
with PCIOL 
17. Dasappan 35 M 87720 
LE EXP. 
KERATITIS 
LEMEDIAL  
TARSORRA
PHY 
18. Etiappan 58 M 891721 LE-IMC 
LE – SICS 
with PCIOL 
19. Mariappan 52 M 792726 LE-IMC 
LE – SICS 
with PCIOL 
20. Shanthi 50 F 811986 
LE- perforated 
corneal ulcer 
LE-TKP 
21. Varadhan 46 M 820826 RE  CDC RE DCR 
22. Rajeshwari 54 F 762091 LE CDC LE DCT 
23. Baskar 52 M 83940 
RE-Mature 
Cataract 
RE – SICS 
with PCIOL 
24 Venkatesh 56 M 78542 LE-IMC LE – SICS 
25. Lakshmi 72 F 84286 
RE-non healing 
corneal ulcer 
RE -  TKP 
Name Age Sex IP No Diagnosis Pre‐op VA
Procedure 
done
Post‐op 
Specular 
week 1
Post‐op 
specular 
month 1
Post‐op 
specular 
month 2
Post‐op specular 
month 6
Post‐op 
specular 
month 12
Status of graft
Post‐op 
VA
Iyyappan 42 M 82632 LE healed opacity 1/60 NIP LE ‐ DALK CD‐1439 CD‐1340 CD‐ 1372
Graft edematous 
Specular‐ not 
Suman Raj 12 M 72311 BE Corneal Dystrophy
5/60 with PH 
6/24
RE‐DALK CD‐3218 CD‐3116 CD‐3098 CD‐ 3106 CD‐3007 Clear graft
3/60  with 
PH 6/24
Ramchandran 74 M 83219
RE Central Macular 
Corneal Opacity
HM + RE‐DALK CD‐1568 CD‐1406
CD‐NOT 
POSSIBLE
Interface 
deposits 
2/60 NIP
Chinamma 50 F 85467
BE‐ Spheroidal 
degeneration
4/60 with 5/60 RE‐DALK CD‐ 1315 CD‐1300 CD‐1298 CD‐1289 CD‐1267
Nagarani 15 F 88932 LE‐Corneal Opacity 2/60 NIP LE‐DALK CD‐3100 CD‐3056 CD‐2972 CD‐2831 CD‐2789 Clear Graft
6/60 with 
PH 6/24
Ramesh 17 M 71176 BE‐Granular Dystrophy 1/60 NIP RE‐DALK CD‐1124 CD‐1119 CD‐1098 CD‐1009 CD‐1004 Clear graft
6/60 with 
PH 6/24
Angeline Linsy 20 F 56813 BE‐Keratoconus 2/60 NIP RE‐DALK CD‐1078 CD‐1279 CD‐1265 CD‐1106 CD‐1075 Clear graft 3/60 NIP
Madhavan 22 M 76145 BE‐Keratoconus 1/60 NIP LE‐DALK CD‐2192 CD‐1876 CD‐1657 Opaque graft CFCF
Raghunathan 15 M 68322 BE‐Keratoconus
2/60 with PH 
3/60
RE‐DALK CD‐1832 CD‐1775 CD‐1798 CD‐1645 CD‐1628 Clear graft
6/24 with 
PH 6/18
Aarthy 18 F 67013 BE‐Keratoconus
2/60 with PH 
6/60
RE‐DALK CD‐2444 CD‐2309 CD‐2310 CD‐2152 CD‐1974 Clear graft
6/60 with 
PH 6/12
Saravanakumar 24 M 98763 BE‐Keratoconus 1/60 NIP LE‐DALK CD‐2418 CD‐2291 CD‐2199 CD‐1972 CD‐1824 Clear Graft
6/18 with 
PH 6/12
Venkataraman 24 M 82154 BE Keratoconus 1/60 NIP LE‐DALK CD‐2992 CD‐2912 CD‐2678 CD‐2156 CD‐2143 Clear graft
2/60 with 
PH 6/36
Sohail Khan 14 M 83467 LE Keratoconus 6/60 NIP LE‐DALK CD‐2501
CD‐not 
possible
CD‐2011 CD‐1825 CD‐1764 Clear graft
6/60 with 
PH 6/24
Kannan 24 M 80158 LE Keratoconus HM LE‐DALK CD‐2111 CD‐1888 CD‐1892 CD‐1924 CD‐1908 Clear graft 1/60 NIP
Gokulavaishnavi 21 F 81345 BE‐ Keratoconus 1/60 nip RE‐DALK CD2988 CD‐2870 CD‐2655 CD‐2500 CD‐2499 Clear Graft 3/60  NIP
Saroja 60 F 82576 BE‐Granular Dystrophy 1/60 NIP LE‐DALK CD‐2401 CD‐2302 CD‐2063 CD‐1945
Recurrence of 
dystrophy
1/60 NIP 
NIG
Rajkamal 18 M 76599
LE‐Corneal 
degeneration
CFCF LE‐DALK CD‐2456 CD‐1892 CD‐1644 CD‐NOT POSSIBLE
Interface 
deposits 
1/60 NIP 
NIG
Palanivel 37 M 83456 BE‐Corneal Dystrophy CFCF LE‐DALK CD‐1768 CD‐1792 CD‐1549 CD‐1527 CD‐1468 Clear graft 6/60 NIP
MASTER CHART
Arumugam 67 M 77718
RE Spheroidal 
Degeneration
CFCF RE‐DALK CD‐1574 CD‐1566 CD1378 CD‐NOT POSSIBLE Graft opaque No PL
Arjunan 49 M 66513
BE Corneal 
degeneration
6/60 NIP LE‐DALK CD‐2483 CD‐2459 CD‐2416 CD‐2387 CD‐2066 Cleatr graft
6/6 with PH 
6/36
Yogalakshmi 12 F 82399 LE Limbal Dermoid
6/36 with PH 
6/24
LE‐DALK
CD‐not 
possible
CD‐2982 CD‐ 2889 CD‐2800 CD‐2776 Clear graft
6/36 with 
PH 6/24
Mumtaz 29 F 75609 BE‐Corneal Dystrophy 2/60 NIP RE‐DALK CD‐2323 CD‐2019 CD‐1765 CD‐1777 CD‐1742
Epithelial 
erosion that  3/60 NIP
Karthik 12 M 70143 RE‐ Corneal Opacity 1/60 NIP RE‐DALK
CD‐not 
possible
CD‐2818 CD‐2655 CD‐2638 CD‐2559 Clear Graft 2/60 NIP
Mustafa 50 F 89833 RE Epithelial Dystrophy 1/2/60 NIP LE‐DALK CD‐1599
Infiltrate in 
the graft
Yakoob 40 M 74567
LE Central Corneal 
Opacity
1/60 NIP LE‐DALK CD‐1738 CD‐1652 CD‐1666 CD‐1659 CD‐1472 Clear graft
6/60 with 
PH 6/24
Masthan 52 M 80909 LE‐Nebular opacity 3/60 NIP LE‐DALK CD‐1422 CD‐1299
Graft 
opaque
LE Regraft PKP done
Malathy 9 F 81234 RE‐ Corneal opacity 6/60 NIP RE‐DALK CD‐3104 CD‐3008 CD‐2997 CD‐2985 CD‐2862 Cleat graft
6/60 with 
ph 6/36
